Yusuke Tanigawara

 

 

  • 2021-present, Advanced Research Project Professor, Pharmacometrics and Systems Pharmacology, Keio University Tonomachi Town Campus, Japan
  • 1998-2021, Professor, Department of Clinical Pharmacokinetics and Pharmacodynamics, Keio University School of Medicine, Japan
  • 1998-2007, Director of Hospital Pharmacy, Keio University Hospital, Japan
  • 1993-1998, Associate Professor and Vice Director, Department of Pharmacy, Kobe University Hospital, Japan
  • 1991-1992, Honorary Research Fellow, School of Pharmacy, University of Manchester, U.K.
  • 1990-1993, Lecturer, Department of Pharmacy, Kyoto University Hospital
  • 1985-1990, Instructor, Department of Pharmacy, Kyoto University Hospital
  • JSPHCS-certified Senior Oncology Pharmacist (JSOP), Japanese Society of Pharmaceutical Health Care and Sciences
  • Board Certified Oncology Pharmacy Specialist (BCOPS), Japanese Society of Hospital Pharmacists
  • Board Certified Supervisor Pharmacist, Japanese Society of Clinical Pharmacology and Therapeutics
  • Board Certified Pharmacist, Japanese Society of Clinical Pharmacology and Therapeutics
  • Pharmacist License of Japan
  • 1983, Ph.D. from Graduate School of Pharmaceutical Sciences, Kyoto University, Japan
  • 1980, MSc from Graduate School of Pharmaceutical Sciences, Kyoto University, Japan
  • 1978, BSc from Faculty of Pharmaceutical Sciences, Kyoto University, Japan
  • 2019-2021, IATDMCT President
  • 2017-2019, IATDMCT President-Elect
  • 2013-2017, IATDMCT Secretary (2 terms)
  • 2017, Chairman, 15th IATDMCT Congress 2017 in Kyoto
  • 2015-2017, Chair of Scientific Committee “TDM in Oncology”
  • Editorial Board, Therapeutic Drug Monitoring
  • 2005-2011, President, Japanese Society of Therapeutic Drug Monitoring (JSTDM)
  • Plenary Lecturer at 14th Congress of IATDMCT 2015 in Rotterdam
  • Plenary Lecturer at 12th Congress of IATDMCT 2011 in Stuttgart
  • Invited speaker at IATDMCT Regional Meeting in Guangzhou, China, 2016
  • Invited speaker at IATDMCT Regional Meeting in Sibiu, Romania, 2014
  • Invited speaker at IATDMCT Regional Meeting in Beijing, China, 2010
  • Symposium speaker and organizer at the IATDMCT Congresses (Vienna in 1995, Cairns in 1999, Montreal in 2009)
  • Number of peer reviewed original articles: 183
  • Book chapters and Review articles: 250
  • Invited lectures at international conferences: 46
  • Invited lectures at Japanese national conferences: 117
  • Dr. Tanigawara was distinguished as “Highly Cited Researcher” by Thomson Reuters ISI database. His research interests include clinical pharmacokinetics, pharmacodynamics and pharmacogenomics and their applications to TDM. He also investigates multi-omics biomarkers by means of MS-based proteomics and metabolomics.
  • 2003-present, Executive Board member, Japanese Society of Therapeutic Drug Monitoring (JSTDM)
  • 2015-present, Executive Board member, Japanese Society of Clinical Oncology (JSCO)
  • 2018-2020, Secretary of International Society of Pharmacometrics (ISoP)
  • 2006-present, President, Population Approach Group in Japan (PAGJA), which was renamed as ‘Pharmacometric Approach Group in Japan’
  • 2016-present, Co-chair, Focus Group “Modeling and Simulation,” International Society for Study of Xenobiotics (ISSX)
  • 2011, Fellow of the Japanese Society for Study of Xenobiotics (JSSX)
  • 2007-2009, Delegate for the Board of Pharmaceutical Sciences, International Pharmaceutical Federation (FIP)
  • 2005-2008 and 2010-2014, Executive Board member, Japanese Society of Clinical Pharmacology and Therapeutics
  • 2008-2016, Executive Board member, Japanese Society of Pharmaceutical Health Care and Science
  • 2007-2009, Executive Board member, The Pharmaceutical Society of Japan
  • 2005-present, Council member, Japanese Society of Clinical Oncology
  • 2007-present, Council member, Japanese Society of Medical Oncology
  • 2009-present, Council member, Japanese Cancer Association
  • 2003-present, Council member, Japanese Society of Chemotherapy
  • 2003-present, Council member, Japanese Society for Pharmacoepidemiology
  • 2002-present, Associated Editor, Cancer Science
  • 2005-present, Editorial Board, Japanese Journal of Clinical Oncology
  • 2010-present, Editorial Board, The Japanese Journal of Antibiotics
  • 1999-2001, Editorial Board, European Journal of Pharmaceutical Sciences
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.